Enabling cellomics with precision single-cell tools for breakthroughs in drug development, diagnostics, and regenerative medicine.
Unlock deeper biological insights and accelerate discovery with single-cell technologies that empower your 3D models and tissue studies. Gain unprecedented precision in cell behavior analysis to enhance drug testing, regenerative medicine, and diagnostics. Integrate high-throughput screening, microfluidics, and robust data analytics into your workflows—driving your personalized medicine initiatives forward.
Power your research with next-generation tools for high-resolution cell analysis.
We combine automated microfluidics, precision labware, and advanced analytics to deliver reproducible, scalable solutions—ideal for cancer research, drug discovery, translational medicine, bioprocessing, and diagnostics.
The synergy between TCR technology and microfluidic prowess has set the stage for a leap in cancer therapy development. By encapsulating individual TCR tests in microscopic droplets, cross-contamination is eliminated, ensuring precise and reliable results. This innovation dramatically accelerates the screening process, turning what used to take months into a matter of weeks, and significantly increasing the number of TCR candidates that can be de-risked in preparation for clinical trials.
Engimmune and CSEM collaborate to accelerate single-cell cancer therapy development.
If you're working on complex challenges in single-cell analysis, drug development, or tissue engineering, we're available to share expertise, discuss potential collaborations, or help you identify the right solutions for your needs. We’re available to help you assess the best approach for your application.
Recent breakthroughs in single-cell technologies are transforming approaches to cancer therapy, tissue engineering, and personalized medicine. These innovative applications demonstrate how laboratory advances are being turned into practical solutions, improving patient care and research capabilities across diverse medical domains.
Explore our use cases powered by single-cell omics and microfluidic innovation.